natgillin/translations-raw huggingface dataset:
Each 6.25 mg tablet contains alogliptin benzoate equivalent to 6.25 mg alogliptin
Üks 6,25 mg tablett sisaldab alogliptiinbensoaati koguses, mis vastab 6,25 mg alogliptiinile.
Each 6.66 ml pipette delivers:
Iga 6,66 ml pipett sisaldab:
Each 60 mg daily dose contains three grey 20 mg capsules.
Üks 60 mg päevane annus koosneb kolmest hallist 20 mg kapslist.
Each 60 mg tablet contains 5.47 mg of lactose.
Iga 60 mg tablett sisaldab 5,47 mg laktoosi.
Each 60 mg tablet contains 60 mg of tolvaptan.
Üks 30 mg tablett sisaldab 30 mg tolvaptaani.
Each 60 mg tablet contains 60 mg tolvaptan.
Üks 30 mg tablett sisaldab 30 mg tolvaptaani.
Each 60 mg tablet contains approximately 16 mg lactose (as monohydrate).
Üks 30 mg tablett sisaldab ligikaudu 70 mg laktoosi (monohüdraadina).
Each 63 microgram pre-filled pen contains 63 micrograms of peginterferon beta-1a in 0.5 mL solution for injection.
Iga 63-mikrogrammine süstel sisaldab 0,5 ml süstelahust, milles on 63 mikrogrammi beeta-1a peginterferooni.
Each 63 microgram pre-filled pen contains 63 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Üks 63-mikrogrammine pen-süstel sisaldab 0,5 ml süstelahuses 63 mikrogrammi beeta-1a* peginterferooni.
Each 63 microgram pre-filled syringe contains 63 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Üks 63-mikrogrammine süstel sisaldab 0,5 ml süstelahuses 63 mikrogrammi beeta-1a* peginterferooni.
Each 7 ml vial of concentrate contains 3.5 ml of ethanol anhydrous (2765 mg).
Iga 7 ml kontsentraadi viaal sisaldab 3,5 ml veevaba etanooli (2765 mg).
Each 7.5 mg pre-filled oral syringe contains 7.5 mg midazolam (as hydrochloride) in 1.5 ml solution.
Iga 7,5 mg suusüstel sisaldab 7,5 mg midasolaami (vesinikkloriidina) 1,5 ml lahuses.
Each 70 mg vial contains 50.0 mg of sucrose.
Iga 70 mg viaal sisaldab 50,0 mg sahharoosi.
Each 75 mg film-coated tablet contains 283 mg lactose.
Üks 75 mg õhukese polümeerikattega tablett sisaldab 283 mg laktoosi.
Each 8 mg prolonged-release tablet contains 0.525 mg of soya lecithin and 58.125 mg of lactose.
Üks 8 mg toimeainet prolongeeritult vabastav tablett sisaldab 0,525 mg sojaletsitiini ja 58,125 mg laktoosi.
Each 8 ml vial of concentrate contains 4 ml of ethanol anhydrous (3160 mg).
Iga 8 ml kontsentraadi viaal sisaldab 4 ml veevaba etanooli (3160 mg).
Each 8.8 micrograms pre-filled pen contains 8.8 micrograms of interferon beta-1a (2.4 million IU).
Üks 8,8 mikrogrammine pen-süstel sisaldab 8,8 mikrogrammi beeta-1a-interferooni (2,4 miljonit RÜ).
Each 8.8 micrograms syringe contains 8.8 micrograms of interferon beta-1a (2.4 million IU).
Üks 8,8 mikrogrammine süstel sisaldab 8,8 mikrogrammi beeta-1a-interferooni (2,4 miljonit RÜ).
Each 80 mg vial contains 0.10 mmol (2.21 mg) sodium.
Iga 80 mg viaal sisaldab 0,10 mmol (2,21 mg) naatriumit.
Each 90 mg tablet contains 8.21 mg of lactose.
Iga 90 mg tablett sisaldab 8,21 mg laktoosi.
Each 90 mg tablet contains 90 mg of tolvaptan.
Üks 30 mg tablett sisaldab 30 mg tolvaptaani.
Each 90 mg tablet contains 90 mg tolvaptan.
Üks 30 mg tablett sisaldab 30 mg tolvaptaani.
Each 90 mg tablet contains approximately 24 mg lactose (as monohydrate).
Üks 30 mg tablett sisaldab ligikaudu 70 mg laktoosi (monohüdraadina).
Each 94 microgram pre-filled pen contains 94 micrograms of peginterferon beta-1a in 0.5 mL solution for injection.
Iga 94-mikrogrammine süstel sisaldab 0,5 ml süstelahust, milles on 94 mikrogrammi beeta-1a peginterferooni.
Each 94 microgram pre-filled pen contains 94 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Üks 94-mikrogrammine pen-süstel sisaldab 0,5 ml süstelahuses 94 mikrogrammi beeta-1a* peginterferooni.
Each 94 microgram pre-filled syringe contains 94 micrograms of peginterferon beta-1a* in 0.5 mL solution for injection.
Üks 94-mikrogrammine süstel sisaldab 0,5 ml süstelahuses 94 mikrogrammi beeta-1a* peginterferooni.
Each 95 mg/23.75 mg modified-release hard capsule contains 95 mg levodopa and 23.75 mg carbidopa (as monohydrate)
Üks 95 mg/23,75 mg toimeainet modifitseeritult vabastav kõvakapsel sisaldab 95 mg levodopat ja 23,75 mg karbidopat (monohüdraadina)
Each 97 mg/103 mg film-coated tablet contains 97.2 mg sacubitril and 102.8 mg valsartan (as sacubitril valsartan sodium salt complex).
Üks 97,2 mg/102,8 mg õhukese polümeerikattega tablett sisaldab 97 mg sakubitriili ja 103 mg valsartaani naatriumisoola kompleksina.
Each 97 mg/103 mg tablet contains 97.2 mg sacubitril and 102.8 mg valsartan (as sacubitril valsartan sodium salt complex).
Üks 97 mg/103 mg tablett sisaldab 9,2 mg sakubitriili ja 102,8 mg valsartaani (sakubitriili valsartaani naatriumisoola kompleksina).
Each actuation delivers 50 microlitres which contains 7.5 mg lidocaine and 2.5 mg prilocaine.
Üks pihus mahuga 50 mikroliitrit sisaldab 7,5 mg lidokaiini ja 2,5 mg prilokaiini.
Each Aerivio Spiromax inhaler contains 60 inhalations and has a white body with a semi-transparent yellow mouthpiece cover.
Üks Aerivio Spiromax inhalaator sisaldab 60 annust, sellel on valge korpus ja poolläbipaistev kollane huulikukate.
Each Aerivio Spiromax inhaler contains 60 inhalations and has a white body with a semi-transparent yellow mouthpiece cover.
Üks Airexar Spiromax inhalaator sisaldab 60 annust, sellel on valge korpus ja poolläbipaistev kollane huulikukate.
Each Aldara 5% cream sachet contains 250 mg of a white to slightly yellow cream.
Iga Aldara 5% kreemi kotike sisaldab 250 mg valget kuni kollakat kreemi.
Each aluminium tube contains 2 g gel and has a polyethylene screw cap.
Iga alumiiniumtuub sisaldab 2 g geeli ja sellel on keeratav polüetüleenkork.
Each AMMONAPS tablet contains 62 mg (2.7 mmol) of sodium, corresponding to 2.5 g (108 mmol) of sodium per 20 g of sodium phenylbutyrate, which is the maximum daily dose.
Iga AMMONAPS’i tablett sisaldab 62 mg ehk 2,7 mmol naatriumi, mis vastab 2,5 g (108 mmol) naatriumile 20g naatriumfenüülbutüraadis, mis on maksimaalne päevane annus.
Each AMMONAPS tablet contains 62 mg of sodium.
Iga AMMONAPS’i tablett sisaldab 62 mg naatriumi.
Each ampoule contains 1 ml of solution for injection.
Iga ampull sisaldab 1 ml süstelahust.
Each ampoule contains 10 mg of arsenic trioxide.
Iga ampull sisaldab 10 mg arseentrioksiidi.
Each ampoule contains 240 mg of levofloxacin,
Üks ampull sisaldab 240 mg levofloksatsiini.
Each ampoule of 2 ml contains 10 mg ibuprofen
Üks 2 ml ampull sisaldab 10 mg ibuprofeeni
Each ampoule with 1 ml solution contains 10 microgram iloprost.
Üks ampull 1 ml lahusega sisaldab 10 mikrogrammi iloprosti.
Each ampoule with 1 ml solution contains 20 microgram iloprost.
Üks ampull 1 ml lahusega sisaldab 20 mikrogrammi iloprosti.
Each ampoule with 2 ml solution contains 20 microgram iloprost.
Üks ampull 2 ml lahusega sisaldab 20 mikrogrammi iloprosti.
Each AVOSTARTCLIP should be used once and then discarded along with any remaining AVONEX in the syringe.
Iga AVOSTARTCLIP’i tohib kasutada ainult ühe korra ja seejärel tuleb see koos süstlasse jäänud AVONEX’iga ära visata.
Each Avostartclip should be used once and then discarded along with any remaining Avonex.
Iga Avostartclip’i tohib kasutada ainult ühe korra ja seejärel tuleb see koos süstlasse jäänud Avonex’iga ära visata.
Each bag contains 100 ml of solution.
Igas kotis on 100 ml lahust.
Each bag contains 177.02 mg sodium.
Üks viaal sisaldab 177,02 mg naatriumi.
Each bag contains 5 mg zoledronic acid (as monohydrate).
Üks kott sisaldab 5 mg zoledroonhapet (Acidum zoledronicum) (monohüdraadina).
Each bag contains 50 ml of sodium chloride 0.9% in Water for Injections.
Üks 50 ml infusioonikott sisaldab 0,9% naatriumkloriidi süstelahust.
Each bag contains a volume of 10-100 mL of frozen dispersion at a concentration of 5-20 x 106 cells/mL.
Kott sisaldab külmutatud dispersiooni mahus 10–100 ml, kontsentratsiooniga 5–20 x 106 rakku/ml.
Each bag of Zalmoxis contains a volume of 10-100 mL of frozen dispersion at the concentration of 5-20 x 106 cells/mL.
Üks Zalmoxis'e kott sisaldab külmutatud dispersiooni mahus 10–100 ml, kontsentratsiooniga 5–20 x 106 rakku/ml.
Each bag with 100 ml of solution contains 4 mg zoledronic acid (as monohydrate).
Iga kott 100 ml lahusega sisaldab 4 mg zoledroonhapet (monohüdraadina).
Each bag with 100 ml of solution contains 5 mg zoledronic acid anhydrous (as monohydrate).
Iga kott 100 ml lahusega sisaldab 5 mg veevaba zoledroonhapet (monohüdraadina).
Each BIO-SET vial contains 30 micrograms (6 million IU) of interferon beta-1a.
Üks BIO-SET viaal sisaldab 30 mikrogrammi (6 miljonit TÜ) beeta-1a interferooni.
Each blister card contains 10 capsules.
Igas blistris on 10 kapslit.
Each blister contains 6 tablets.
Igas blistris on 6 tabletti.
Each blister contains 7 tablets.
Igas blistris on 7 tabletti.
Each blister contains 7 x 1 film-coated tablets and is packed together with a desiccant sachet in an aluminium pouch.
Iga blister sisaldab 7 x 1 õhukese polümeerikattega tabletti ning on pakitud koos kuivatusaine kotikesega alumiiniumkotti.
Each blister pack contains 30 or 90 film-coated tablets.
Ühes blistritega pakendis on 30 või90 õhukese polümeerikattega tabletti.
Each blister pack contains:
Iga blisterpakend sisaldab:
Each bottle contains 100 ml of solution
Iga pudel sisaldab 100 ml lahust.
Each bottle contains 100 ml of solution.
Igas pudelis on 100 ml lahust.
Each bottle contains 120 tablets.
Iga pudel sisaldab 120 tabletti.
Each bottle contains 14 tablets and a silica gel desiccant.
Iga pudel sisaldab 14 tabletti ja niiskust imavat ainet ränigeeli.
Each bottle contains 15 ml Brintellix oral drops, solution.
Iga pudel sisaldab 15 ml Brintellix’i suukaudseid tilku, lahust.
Each bottle contains 2.5 mL of travoprost eye drops and each bottle is placed in a pouch.
Iga pudel sisaldab 2,5 ml travoprost silmatilkasid ja iga pudel on pakendatud eraldi ümbrisesse.
Each bottle contains 2.5 mL of travoprost eye drops and each bottle is placed in a pouch.
Üks pudel sisaldab 2,5 ml travoprosti silmatilku ning iga pudel on eraldi ümbrises.
Each bottle contains 240 ml oral solution
Iga pudel sisaldab 240 ml suukaudset lahust
Each bottle contains 240 ml oral solution The pack contains an oral applicator.
Iga pudel sisaldab 240 ml suukaudset lahust Pakendis on suukaudne aplikaator.
Each bottle contains 250 ml sevoflurane (100%).
Üks pudel sisaldab 250 ml sevofluraani (100%).
Each bottle contains 30 tablets or 180 tablets.
Iga pudel sisaldab 30 tabletti või 180 tabletti.
Each bottle contains 35 g mycophenolate mofetil in 110 g powder for oral suspension.
Üks pudel 110 g suukaudse suspensiooni pulbriga sisaldab 35 mg mükofenolaatmofetiili (vesinikkloriidsoolana).
Each bottle contains 35 g mycophenolate mofetil in 110 g powder for oral suspension.
Üks pudel sisaldab 35 g mükofenolaatmofetiili 110 g suukaudse suspensiooni pulbris.
Each bottle contains 45 g of powder providing 70 ml of suspension when constituted with water as recommended.
Üks pudel sisaldab 45 g pulbrit, millest saab 70 ml valmis suspensiooni.
Each bottle contains 5 mg zoledronic acid (as monohydrate).
Iga pudel sisaldab 5 mg zoledroonhapet (Acidum zoledronicum) (monohüdraadina).
Each bottle contains 5 mg zoledronic acid (as monohydrate).
Iga pudel sisaldab 5 mg zoledroonhapet (monohüdraadina).
Each bottle contains 90 ml oral suspension.
Iga pudel sisaldab 90 ml suukaudset suspensiooni.
Each bottle contains 90 ml supension.
Iga pudel sisaldab 90 ml suspensiooni.
Each bottle contains a small plastic tube of desiccant (silica gel).
Igas pudelis on väike plastiktuub kuivatusainega (silikageel).
Each bottle contains either 270 or 300 tablets.
Iga pudel sisaldab 270 või 300 tabletti.
Each bottle contains either 30 tablets or 350 tablets.
Iga pudel sisaldab kas 30 või 350 tabletti.
Each bottle contains stavudine 200 mg
Iga purk sisaldab 200 mg stavudiini
Each bottle has a fill volume of 3 ml.
Iga pudel on täidetud mahuni 3 ml.
Each bottle has a fill volume of 3 ml.
Iga pudeli maht on 3 ml.
Each bottle holds 30 tablets.
Igas karbis on 30 tabletti.
Each bottle is about half full and contains 3 millilitres of solution.
Iga pudel on täidetud umbes pooleni ja sisaldab 3 ml lahust.
Each bottle is approximately half full and contains 3 millilitres of solution.
Iga pudel on ligikaudu poolenisti täis ning sisaldab 3 ml lahust.
Each bottle is packed in a carton.
Iga pudel on pakitud pappkarpi.
Each bottle may be placed in a pouch.
Iga pudel võib olla kotikeses.
Each bottle of 100 ml contains 5 mg zoledronic acid (as monohydrate).
Üks pudel 100 ml lahusega sisaldab 5 mg zoledroonhapet (monohüdraadina).
Each bottle of 110 g powder for oral suspension contains 35 g of mycophenolate mofetil.
Üks pudel 110 g suukaudse suspensiooni pulbriga sisaldab 35 g mükofenolaatmofetiili.
Each bottle of Kuvan contains a small plastic tube of desiccant (silica gel).
Iga Kuvan’i pudel sisaldab väikest plastiktuubi kuivatusainega (silikageel).
Each bottle should be discarded after 3 days.
Iga pudel tuleb 3 päeva möödumisel ära visata.
Each bottle with 100 ml of solution contains 5 mg zoledronic acid (as monohydrate).
Üks pudel 100 ml lahusega sisaldab 5 mg zoledroonhapet (Acidum zoledronicum) (monohüdraadina).
Each bottle with 100 ml of solution contains 5 mg zoledronic acid (as monohydrate).
Üks pudel sisaldab 5 mg zoledroonhapet (monohüdraadina).
Each box contains 12 or 24 single-use polyester/aluminium foil sachets.
Igas karbis on 12 või 24 ühekordselt kasutatavat polüester/alumiiniumfooliumkotikest.
Each box contains 14, 28 or 56 single-use polyester/ white low density polyethylene/aluminium foil sachets.
Igas karbis on kas 14, 28 või 56 üksikannusega polüester/valge madala tihedusega polüetüleen/alumiiniumfooliumist kotikest.
Each box contains 2, 4 or 8 blisters.
Iga karp sisaldab 2, 4 või 8 blisterpakendit.
Each box contains 28, 56 or 112 capsules.
Iga karp sisaldab 28, 56 või 112 kapslit.
Each box contains one Docetaxel Teva vial (20 mg) and one corresponding solvent for Docetaxel Teva vial in a carton.
Igas karbis on üks Docetaxel Teva viaal (20 mg) ja üks sellele vastav Docetaxel Teva lahusti viaal karbis.
Each box contains one Docetaxel Teva vial (80 mg) and one corresponding solvent for Docetaxel Teva vial in a carton.
Igas karbis on üks Docetaxel Teva viaal (80 mg) ja üks sellele vastav Docetaxel Teva lahusti viaal karbis.
Each buccal tablet contains 100 micrograms fentanyl (as citrate).
Iga bukaaltablett sisaldab 100 mikrogrammi fentanüüli (tsitraadina).
Each buccal tablet contains 200 micrograms fentanyl (as citrate).
Iga bukaaltablett sisaldab 200 mikrogrammi fentanüüli (tsitraadina).
Each buccal tablet contains 400 micrograms fentanyl (as citrate).
Iga bukaaltablett sisaldab 400 mikrogrammi fentanüüli (tsitraadina).
Each buccal tablet contains 600 micrograms fentanyl (as citrate).
Iga bukaaltablett sisaldab 600 mikrogrammi fentanüüli (tsitraadina).
Each buccal tablet contains 800 micrograms fentanyl (as citrate).
Iga bukaaltablett sisaldab 800 mikrogrammi fentanüüli (tsitraadina).
Each capsule card contains 8 capsules (corresponding to a daily dose: content of 4 capsules to be inhaled in the morning and content of 4 capsules to be inhaled in the evening).
Igas kapslikaardis on 8 kapslit (vastavalt päevasele annusele: 4 kapsli sisu tuleb sisse hingata hommikul ja 4 kapsli sisu tuleb sisse hingata õhtul).
Each capsule contains 0.5 mg fingolimod (as hydrochloride).
Üks kapsel sisaldab 0,5 mg fingolimoodi (vesinikkloriidina).
Each capsule contains 0.5 mg fingolimod (as hydrochloride).
Üks kõvakapsel sisaldab 0,5 mg fingolimoodi (Fingolimodum) (vesinikkloriidina).
Each capsule contains 1 mg of pomalidomide.
Iga kapsel sisaldab 1 mg pomalidomiidi.
Each capsule contains 1,662,500 IU (approximately equal to 125 mg) of colistimethate sodium
Üks kapsel sisaldab 1 662 500 RÜ (ligikaudu 125 mg) naatriumkolistiinmetaati.
Each capsule contains 1.75 mg of sunset yellow FCF (E110)
Iga kapsli kest sisaldab 1,75 mg päikeseloojangukollast FCF (E110)
Each capsule contains 1.8 mg of soya lecithin.
Üks kapsel sisaldab 1,8 mg sojaletsitiini.
Each capsule contains 10 mg lenalidomide.
Iga kapsel sisaldab 10 mg lenalidomiidi.
Each capsule contains 10 mg of zaleplon.
Iga kapsel sisaldab 10 mg zaleplooni.
Each capsule contains 100 mg imatinib (as mesilate).
Iga kapsel sisaldab 100 mg imatiniibi (mesülaadina).
Each capsule contains 100 mg isavuconazole (as 186.3 mg isavuconazonium sulfate).
Üks kapsel sisaldab 100 mg isavukonasooli (186,3 mg isavukonasoonsulfaadina)
Each capsule contains 100 mg of atazanavir (as sulphate).
Kapsel sisaldab 100 mg atasanaviiri (sulfaadina).
Each capsule contains 100 mg of atazanavir (as sulphate).
Üks kapsel sisaldab 100 mg atasanaviiri (sulfaadina).
Each capsule contains 100 mg of imatinib (as mesilate).
Iga kapsel sisaldab 100 mg imatiniibi (mesülaadina).
Each capsule contains 100 mg temozolomide.
Iga kapsel sisaldab 100 mg temosolomiidi.
Each capsule contains 106 mg lactose (as monohydrate).
Üks kapsel sisaldab 106 mg laktoosi (monohüdraadina).
Each capsule contains 120 mg dimethyl fumarate
Üks kapsel sisaldab 120 mg dimetüülfumaraati
Each capsule contains 120 mg dimethyl fumarate.
Üks kapsel sisaldab 120 mg dimetüülfumaraati (dimethylis fumaras).
Each capsule contains 120 mg orlistat.
Iga kapsel sisaldab 120 mg orlistati.
Each capsule contains 125 mg of sucrose (in the 125 mg capsule).
Iga kapsel sisaldab 125 mg sahharoosi (125 mg kapslis).
Each capsule contains 14.21 milligrams sorbitol.
Kapsel sisaldab 14,21 milligrammi sorbitooli.
Each capsule contains 140 mg of ibrutinib
Üks kapsel sisaldab 140 mg ibrutiniibi
Each capsule contains 140 mg temozolomide.
Iga kapsel sisaldab 140 mg temosolomiidi.
Each capsule contains 143 µg of indacaterol maleate equivalent to 110 µg of indacaterol and 63 µg of glycopyrronium bromide equivalent to 50 µg of glycopyrronium.
Üks kapsel sisaldab 143 µg indakateroolmaleaati (Indacateroli maleas), mis vastab 110 µg indakateroolile (Indacaterolum) ja 63 µg glükopürrooniumbromiidi (Glycopyrronii bromidum), mis vastab 50 µg glükopürrooniumile (Glycopyrronium).
Each capsule contains 144.5 mg of lactose, anhydrous.
Iga kapsel sisaldab 144,5 mg veevaba laktoosi.
Each capsule contains 145 mg levodopa and 36.25 mg carbidopa (as monohydrate)
Üks kapsel sisaldab 145 mg levodopat ja 36,25 mg karbidopat (monohüdraadina)
Each capsule contains 147 mg of lactose, anhydrous.
Iga kapsel sisaldab 147 mg veevaba laktoosi.
Each capsule contains 15 mg lenalidomide.
Iga kapsel sisaldab 15 mg lenalidomiidi.
Each capsule contains 150 mg amprenavir
Kapsel sisaldab 150 mg amprenaviiri.
Each capsule contains 150 mg amprenavir.
Kapsel sisaldab 150 mg amprenaviiri.
Each capsule contains 150 mg of atazanavir (as sulphate).
Kapsel sisaldab 150 mg atasanaviiri (sulfaadina).
Each capsule contains 150 mg of atazanavir (as sulphate).
Üks kapsel sisaldab 150 mg atasanaviiri (sulfaadina).
Each capsule contains 150 mg of vismodegib.
Üks kapsel sisaldab 150 mg vismodegiibi.
Each capsule contains 165 mg of sucrose.
Iga kapsel sisaldab 165 mg sahharoosi.
Each capsule contains 180 mg temozolomide.
Iga kapsel sisaldab 180 mg temosolomiidi.
Each capsule contains 195 mg levodopa and 48.75 mg carbidopa (as monohydrate)
Üks kapsel sisaldab 195 mg levodopat ja 48,75 mg karbidopat (monohüdraadina)
Each capsule contains 2 mg of pomalidomide.
Iga kapsel sisaldab 2 mg pomalidomiidi.
Each capsule contains 2.5 mg lenalidomide.
Iga kapsel sisaldab 2,5 mg lenalidomiidi.
Each capsule contains 20 mg lenalidomide.
Iga kapsel sisaldab 20 mg lenalidomiidi.
Each capsule contains 20 mg of duloxetine (as hydrochloride)
Iga kapsel sisaldab 20 mg duloksetiini (vesinikkloriidina)
Each capsule contains 20 mg of duloxetine (as hydrochloride).
Iga kapsel sisaldab 20 mg duloksetiini (vesinikkloriidina).
Each capsule contains 20 mg temozolomide.
Iga kapsel sisaldab 20 mg temosolomiidi.
Each capsule contains 200 mg celecoxib
Üks kapsel sisaldab 200 mg tselekoksiibi
Each capsule contains 200 mg of atazanavir (as sulphate).
Kapsel sisaldab 200 mg atasanaviiri (sulfaadina).
Each capsule contains 200 mg of atazanavir (as sulphate).
Üks kapsel sisaldab 200 mg atasanaviiri (sulfaadina).
Each capsule contains 200 mg of celecoxib.
Iga kapsel sisaldab 200 mg tselekoksiibi.
Each capsule contains 200 mg of lactose, anhydrous.
Iga kapsel sisaldab 200 mg veevaba laktoosi.
Each capsule contains 23.5 mg lactose (as monohydrate).
Üks kapsel sisaldab 23,5 mg laktoosi (monohüdraadina).
Each capsule contains 23.6 mg lactose (as monohydrate).
Üks kapsel sisaldab 23,6 mg laktoosi (monohüdraadina).
Each capsule contains 240 mg dimethyl fumarate
Üks kapsel sisaldab 240 mg dimetüülfumaraati
Each capsule contains 244.5 mg of lactose, anhydrous.
Iga kapsel sisaldab 244.5 mg veevaba laktoosi.
Each capsule contains 245 mg levodopa and 61.25 mg carbidopa (as monohydrate) For the full list of excipients, see section 6.1.
Üks kapsel sisaldab 245 mg levodopat ja 61,25 mg karbidopat (monohüdraadina) Abiainete täielik loetelu vt lõik 6.1.
Each capsule contains 25 mg lenalidomide.
Iga kapsel sisaldab 25 mg lenalidomiidi.
Each capsule contains 25 mg of cysteamine (as mercaptamine bitartrate).
Üks kõvakapsel sisaldab 25 mg tsüsteamiini (merkaptamiinbitartraadina).
Each capsule contains 250 mg cholic acid
Üks kõvakapsel sisaldab 250 mg koolhapet.
Each capsule contains 250 mg mycophenolate mofetil
Üks kapsel sisaldab 250 mg mükofenolaatmofetiili
Each capsule contains 250 mg mycophenolate mofetil.
Üks kapsel sisaldab 250 mg mükofenolaatmofetiili
Each capsule contains 250 mg of stiripentol.
Üks kapsel sisaldab 250 mg stiripentooli.
Each capsule contains 250 mg temozolomide.
Iga kapsel sisaldab 250 mg temosolomiidi.
Each capsule contains 267 mg pirfenidone.
Iga kapsel sisaldab 267 mg pirfenidooni.
Each capsule contains 289 mg of lactose, anhydrous.
Iga kapsel sisaldab 289 mg veevaba laktoosi.
Each capsule contains 290 micrograms of linaclotide
Iga kapsel sisaldab 290 mikrogrammi linaklotiidi.
Each capsule contains 290 micrograms of linaclotide.
Üks kapsel sisaldab 290 mikrogrammi linaklotiidi.
Each capsule contains 294 mg of lactose, anhydrous.
Iga kapsel sisaldab 294 mg veevaba laktoosi.
Each capsule contains 3 mg of pomalidomide.
Iga kapsel sisaldab 3 mg pomalidomiidi.
Each capsule contains 30 mg iron (as ferric maltol).
Üks kapsel sisaldab 30 mg rauda (raud(III)maltoolina).
Each capsule contains 30 mg of duloxetine (as hydrochloride)
Iga kapsel sisaldab 30 mg duloksetiini (vesinikkloriidina)
Each capsule contains 30 mg of duloxetine (as hydrochloride)
Iga kapsel sisaldab 30 mg duloksetiini vesinikkloriidina
Each capsule contains 300 mg of atazanavir (as sulphate).
Kapsel sisaldab 300 mg atasanaviiri (sulfaadina).
Each capsule contains 300 mg of atazanavir (as sulphate).
Üks kapsel sisaldab 300 mg atasanaviiri (sulfaadina).
Each capsule contains 300 mg of netupitant, and palonosetron hydrochloride equivalent to 0.5 mg of palonosetron.
Üks kapsel sisaldab 300 mg netupitanti ja palonosetroonvesinikkloriidi koguses, mis vastab 0,5 mg palonosetroonile.
Each capsule contains 300 milligrams of netupitant and 0.5 milligrams of palonosetron (as hydrochloride).
Üks kapsel sisaldab 300 milligrammi netupitanti ja 0,5 milligrammi palonosetrooni (vesinikkloriidina).
Each capsule contains 4 mg of pomalidomide
Iga kapsel sisaldab 4 mg pomalidomiidi.
Each capsule contains 4 mg of pomalidomide.
Iga kapsel sisaldab 4 mg pomalidomiidi.
Each capsule contains 40 mg enzalutamide.
Iga kapsel sisaldab 40 mg ensalutamiidi.
Each capsule contains 40 mg of aprepitant.
Kapsel sisaldab 40 mg aprepitanti.
Each capsule contains 40 mg of duloxetine (as hydrochloride)
Iga kapsel sisaldab 40 mg duloksetiini (vesinikkloriidina)
Each capsule contains 40 mg of duloxetine (as hydrochloride).
Iga kapsel sisaldab 40 mg duloksetiini (vesinikkloriidina).
Each capsule contains 40 mg of enzalutamide.
Üks kapsel sisaldab 40 mg ensalutamiidi.
Each capsule contains 40 mg of pravastatin sodium and 160 mg of fenofibrate
Iga kapsel sisaldab 40 mg naatriumpravastatiini ja 160 mg fenofibraati.
Each capsule contains 40 mg of pravastatin sodium and 160 mg of fenofibrate.
Iga kapsel sisaldab 40 mg of naatriumpravastatiini ja 160 mg fenofibraati.
Each capsule contains 40 mg of sucrose.
Iga kapsel sisaldab 40 mg sahharoosi.
Each capsule contains 40 milligrams mannitol.
Iga kapsel sisaldab 40 mg mannitooli.
Each capsule contains 400 mg celecoxib
Üks kapsel sisaldab 400 mg tselekoksiibi